-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DYEpP8yL5gfixStJroMCc/swsQkOOLmpUKSma+zBpjV6bHkJj5JgAduhWD0e/pbb fczX5qRbVlaQoAKc5TkhlA== 0000927016-02-000061.txt : 20020413 0000927016-02-000061.hdr.sgml : 20020413 ACCESSION NUMBER: 0000927016-02-000061 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020103 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VISIBLE GENETICS INC CENTRAL INDEX KEY: 0001010819 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-49801 FILM NUMBER: 2501407 BUSINESS ADDRESS: STREET 1: 700 BAY ST STREET 2: SUITE 1000 CITY: TORONTO ONTARIO CANA STATE: A6 ZIP: 00000 BUSINESS PHONE: 2127025700 MAIL ADDRESS: STREET 1: 700 BAY ST STE 1000 STREET 2: TORONTO ONTARIO CANADA CITY: M5G 1Z6 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GADICKE ANSBERT CENTRAL INDEX KEY: 0001134655 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6172257054 MAIL ADDRESS: STREET 1: ONE CAMBRIDGE CENTER CITY: CAMBRIDGE STATE: MA ZIP: 02142 SC 13G 1 dsc13g.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(b) VISIBLE GENETICS INC. -------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK -------------------------------------------------------------------------- (Title of Class of Securities) 92829S104 -------------------------------------------------------------------------- (CUSIP Number) Check the appropriate box to designate the one pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [x] Rule 13d-1(c) [_] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ----------------------- --------------------- CUSIP NO. 92829S104 13G Page 2 of 6 Pages - ----------------------- --------------------- - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1. S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Ansbert S. Gadicke - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2. (a) [_] (b) [X] - ------------------------------------------------------------------------------ SEC USE ONLY 3. - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4. United States - ------------------------------------------------------------------------------ SOLE VOTING POWER 5. NUMBER OF 1,351,937(1) SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6. OWNED BY None ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7. REPORTING 1,351,937(1) PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8. None - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9. 1,351,937(1) - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10. [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11. 6.3% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12. IN - ------------------------------------------------------------------------------ *SEE INSTRUCTIONS BEFORE FILLING OUT! - ------------------------ ------------------------ CUSIP NO. 92829S104 13G Page 3 of 6 Pages - ------------------------ ------------------------ Item 1 (a). Name of Issuer: Visible Genetics Inc. ----------------------------------------------------------------------- Item 1(b). Address of Issuer's Principal Executive Offices: 700 Bay Street, Suite 1000, Toronto ON, Canada M5G 1Z6 ----------------------------------------------------------------------- Item 2(a). Name of Person Filing: Ansbert S. Gadicke ----------------------------------------------------------------------- Item 2(b). Address of Principal Business Office or, if none, Residence: c/o MPM Capital L.P. 601 Gateway Blvd., Suite 350 South San Francisco, CA 94080 ----------------------------------------------------------------------- Item 2(c). Citizenship: United States ----------------------------------------------------------------------- Item 2(d). Title of Class of Securities: Common Stock ----------------------------------------------------------------------- Item 2(e). CUSIP Number: 92829S104 ----------------------------------------------------------------------- - ----------------------- ------------------------ CUSIP NO. 92829S104 13G Page 4 of 6 Pages - ----------------------- ------------------------ Item 3. If This Statement Is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: Not Applicable --------------------------------------------------------------------- Item 4. Ownership. (a) Amount beneficially owned: 1,351,937 shares of common stock (1) --------------------------------------------------------------------- (b) Percent of class: 6.3% --------------------------------------------------------------------- (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 1,351,937 (1) ------------------------- (ii) shared power to vote or to direct the vote: None ------------------------- (iii) sole power to dispose or to direct the disposition of: 1,351,937(1) ------------------------- (iv) shared power to dispose or to direct the disposition of: None -------------------------
Item 5. Ownership of Five Percent or Less of a Class. Not Applicable --------------------------------------------------------------------- Item 6. Ownership of More than Five Percent on Behalf of Another Person. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares to which this statement relates. No one person's interest in such shares is more than five percent of the total outstanding stock of the Issuer. --------------------------------------------------------------------- Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable --------------------------------------------------------------------- - ---------------------- ------------------------ CUSIP NO. 92829S104 13G Page 5 of 6 Pages - ---------------------- ------------------------ Item 8. Identification and Classification of Members of the Group. Not Applicable --------------------------------------------------------------------- Item 9. Notice of Dissolution of Group. Not Applicable --------------------------------------------------------------------- Item 10. Certifications. Not Applicable --------------------------------------------------------------------- (1) Includes shares held through interests in MPM Capital II GP LLC, the control person of MPM BioEquities Adviser LLC ("MPM BioEquities Adviser") and entities advised and/or managed by MPM BioEquities Adviser and the general partners of such entities. MPM BioEquities Adviser is the adviser of MPM BioEquities Master Fund L.P., the direct and indirect general partners of which are MPM BioEquities GP L.P. and MPM BioEquities GP LLC. 1,351,937 of the shares are held of record by MPM BioEquities Master Fund L.P. The reporting person disclaims beneficial ownership of shares not directly held by him. - ----------------------- ----------------------- CUSIP NO. 92829S104 13G Page 6 of 6 Pages - ----------------------- ----------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 3, 2002 ----------------------------------- Date /s/ Ansbert S. Gadicke ----------------------------------- Signature Ansbert S. Gadicke ----------------------------------- Name/Title -----END PRIVACY-ENHANCED MESSAGE-----